• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床、实验室和起搏预测 CRT 反应。

Clinical, laboratory, and pacing predictors of CRT response.

机构信息

Cardiac Arrhythmia Service, Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

出版信息

J Cardiovasc Transl Res. 2012 Apr;5(2):196-212. doi: 10.1007/s12265-012-9352-0. Epub 2012 Feb 24.

DOI:10.1007/s12265-012-9352-0
PMID:22362181
Abstract

A decade of research has established the role of cardiac resynchronization therapy (CRT) in medically refractory, moderate to severe systolic heart failure (HF) with intraventricular conduction delay. CRT is an electrical therapy instituted to reestablish ventricular synchronization in order to improve cardiac function and favorably modulate the neurohormonal system. CRT confers a mortality benefit, improved HF hospitalizations, and functional outcome in this population, but not all patients consistently demonstrate a positive CRT response. The nonresponder rate varies from 20% to 40%, depending on the defined response criteria. Efforts to improve response to CRT have focused on a number of fronts. Methods to optimize the correction of electrical and mechanical dyssynchrony, which is the primary target of CRT, has been the focus of research, in addition to improving patient selection and optimizing post-implant care. However, a major issue in dealing with improving nonresponse rates has been finding an accurate and generally accepted definition of "response" itself. The availability of a standard consensus definition of CRT response would enable the estimation of nonresponder burden accurately and permit the development of strategies to improve CRT response. In this review, we define various aspects of "response" to CRT and outline variability in the definition criteria and the problems with its inconsistencies. We describe clinical, laboratory, and pacing predictors that influence CRT response and outcome and how to optimize response.

摘要

经过十年的研究,心脏再同步治疗(CRT)在药物难治性、中度至重度收缩性心力衰竭(HF)伴室内传导延迟中的作用已经确立。CRT 是一种电治疗方法,旨在重建心室同步,以改善心功能并有利地调节神经激素系统。CRT 为该人群提供了死亡率益处、改善 HF 住院和功能结局,但并非所有患者都始终表现出积极的 CRT 反应。根据定义的反应标准,无反应者的比率在 20%至 40%之间变化。改善 CRT 反应的努力集中在多个方面。除了改善患者选择和优化植入后护理外,还致力于优化电和机械不同步的纠正方法,这是 CRT 的主要目标,这也是研究的重点。然而,在提高无反应率方面的一个主要问题是找到“反应”本身的准确且普遍接受的定义。CRT 反应的标准共识定义的可用性将能够准确估计无反应者的负担,并允许制定改善 CRT 反应的策略。在这篇综述中,我们定义了 CRT 反应的各个方面,并概述了定义标准的可变性及其不一致性的问题。我们描述了影响 CRT 反应和结局的临床、实验室和起搏预测因素,以及如何优化反应。

相似文献

1
Clinical, laboratory, and pacing predictors of CRT response.临床、实验室和起搏预测 CRT 反应。
J Cardiovasc Transl Res. 2012 Apr;5(2):196-212. doi: 10.1007/s12265-012-9352-0. Epub 2012 Feb 24.
2
Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).比较低脉压(<40mmHg)与高脉压(>40mmHg)对预测心力衰竭心脏再同步治疗获益的价值(来自多中心自动除颤器植入试验-心脏再同步治疗试验)。
Am J Cardiol. 2014 Oct 1;114(7):1053-8. doi: 10.1016/j.amjcard.2014.07.014. Epub 2014 Jul 17.
3
Optimization of left ventricular pacing site plus multipoint pacing improves remodeling and clinical response to cardiac resynchronization therapy at 1 year.左心室起搏部位优化联合多点起搏可改善1年时的心脏重构及心脏再同步治疗的临床反应。
Heart Rhythm. 2016 Aug;13(8):1644-51. doi: 10.1016/j.hrthm.2016.05.015.
4
Effect of Diabetes Mellitus on Cardiac Resynchronization Therapy and to Prognosis in Heart Failure (from the Prospective Evaluation of Asian With Cardiac Resynchronization Therapy for Heart Failure Study).糖尿病对心力衰竭心脏再同步治疗效果及预后的影响(来自亚洲心力衰竭心脏再同步治疗前瞻性评估研究)。
Am J Cardiol. 2019 Sep 15;124(6):899-906. doi: 10.1016/j.amjcard.2019.06.004. Epub 2019 Jun 24.
5
Cardiac resynchronization therapy by left bundle branch area pacing in patients with heart failure and left bundle branch block.左束支区域起搏治疗心力衰竭伴左束支传导阻滞患者的心脏再同步治疗。
Heart Rhythm. 2019 Dec;16(12):1783-1790. doi: 10.1016/j.hrthm.2019.09.006. Epub 2019 Sep 9.
6
Left ventricular endocardial pacing and multisite pacing to improve CRT response.左心室心内膜起搏和多点起搏改善 CRT 反应。
J Cardiovasc Transl Res. 2012 Apr;5(2):213-8. doi: 10.1007/s12265-011-9342-7. Epub 2012 Jan 11.
7
The role of interventricular conduction delay to predict clinical response with cardiac resynchronization therapy.室间传导延迟在心脏再同步治疗中预测临床反应的作用。
Heart Rhythm. 2017 Dec;14(12):1748-1755. doi: 10.1016/j.hrthm.2017.10.016.
8
Assessment of mechanical dyssynchrony in cardiac resynchronization therapy.心脏再同步治疗中机械性不同步的评估。
Dan Med J. 2014 Dec;61(12):B4981.
9
On-treatment comparison between corrective His bundle pacing and biventricular pacing for cardiac resynchronization: A secondary analysis of the His-SYNC Pilot Trial.校正希氏束起搏与双心室起搏治疗心脏再同步化的治疗中比较:His-SYNC 试验的二次分析。
Heart Rhythm. 2019 Dec;16(12):1797-1807. doi: 10.1016/j.hrthm.2019.05.009. Epub 2019 May 13.
10
Prevention of non-response to cardiac resynchronization therapy: points to remember.预防心脏再同步治疗无应答:需要记住的要点。
Heart Fail Rev. 2020 Mar;25(2):269-275. doi: 10.1007/s10741-019-09834-w.

引用本文的文献

1
Conduction system pacing on track to replace CRT? Review of current evidence and prospects of conduction system pacing.传导系统起搏有望取代心脏再同步治疗?当前证据及传导系统起搏前景综述
Front Cardiovasc Med. 2023 Aug 15;10:1220709. doi: 10.3389/fcvm.2023.1220709. eCollection 2023.
2
Short QRS Duration After His-Purkinje Conduction System Pacing Predicts Left Ventricular Complete Reverse Remodeling in Patients With True Left Bundle Branch Block and Heart Failure.希氏-浦肯野传导系统起搏后QRS波时限缩短可预测真正左束支传导阻滞和心力衰竭患者左心室完全逆向重构。
Front Cardiovasc Med. 2022 May 6;9:824194. doi: 10.3389/fcvm.2022.824194. eCollection 2022.
3

本文引用的文献

1
Reduced septal glucose metabolism predicts response to cardiac resynchronization therapy.室间隔葡萄糖代谢降低可预测心脏再同步化治疗的反应。
J Nucl Cardiol. 2012 Feb;19(1):73-83. doi: 10.1007/s12350-011-9483-8. Epub 2011 Dec 10.
2
Impact of mitral regurgitation on the outcome of patients treated with CRT-D: data from the InSync ICD Italian Registry.二尖瓣反流对接受心脏再同步化治疗除颤器(CRT-D)患者预后的影响:来自意大利InSync ICD注册研究的数据
Pacing Clin Electrophysiol. 2012 Feb;35(2):146-54. doi: 10.1111/j.1540-8159.2011.03280.x. Epub 2011 Dec 2.
3
Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial.
Sex-Specific Differences in Ventricular Remodeling and Response After Cardiac Resynchronization Therapy.
性别特异性心室重构差异与心脏再同步化治疗后的反应
Am J Cardiol. 2022 Jul 1;174:68-75. doi: 10.1016/j.amjcard.2022.03.021. Epub 2022 Apr 23.
4
Comparative effects of left bundle branch area pacing, His bundle pacing, biventricular pacing in patients requiring cardiac resynchronization therapy: A network meta-analysis.比较左束支区域起搏、希氏束起搏、双心室起搏在需要心脏再同步治疗患者中的效果:网状荟萃分析。
Clin Cardiol. 2022 Feb;45(2):214-223. doi: 10.1002/clc.23784. Epub 2022 Feb 7.
5
Guidewire Method for Measuring Local Left Ventricular Electrical Activation Time During Cardiac Resynchronization Implantation.心脏再同步化植入术中测量局部左心室电激活时间的导丝法
J Innov Card Rhythm Manag. 2018 Jan 15;9(1):2989-2995. doi: 10.19102/icrm.2018.090102. eCollection 2018 Jan.
6
Cardiac Resynchronization Therapy-Emerging Therapeutic Approaches.心脏再同步治疗——新兴治疗方法
Curr Treat Options Cardiovasc Med. 2018 Mar 6;20(3):20. doi: 10.1007/s11936-018-0614-2.
7
Development and Validation of Predictive Models of Cardiac Mortality and Transplantation in Resynchronization Therapy.心脏再同步治疗中心脏死亡率和移植预测模型的开发与验证
Arq Bras Cardiol. 2015 Oct;105(4):399-409. doi: 10.5935/abc.20150093. Epub 2015 Aug 7.
8
Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review.心脏再同步治疗诱导左心室功能恢复后,合适的植入式心律转复除颤器治疗减少:一项荟萃分析和系统评价
Eur Heart J. 2015 Nov 1;36(41):2780-9. doi: 10.1093/eurheartj/ehv373. Epub 2015 Aug 10.
9
Predictors of mortality, LVAD implant, or heart transplant in primary prevention cardiac resynchronization therapy recipients: The HF-CRT score.一级预防心脏再同步治疗受者死亡、左心室辅助装置植入或心脏移植的预测因素:心力衰竭心脏再同步治疗评分
Heart Rhythm. 2015 Dec;12(12):2387-94. doi: 10.1016/j.hrthm.2015.07.026. Epub 2015 Jul 17.
10
Guidelines for translational research in heart failure.心力衰竭转化研究指南。
J Cardiovasc Transl Res. 2015 Feb;8(1):3-22. doi: 10.1007/s12265-015-9606-8. Epub 2015 Jan 21.
心脏衰竭、左心室功能障碍和不同步患者中半乳糖凝集素-3 和纤维化标志物与长期心血管结局的关系:来自 CARE-HF(心脏再同步治疗心力衰竭)试验的见解。
Eur J Heart Fail. 2012 Jan;14(1):74-81. doi: 10.1093/eurjhf/hfr151. Epub 2011 Nov 16.
4
Endocardial left ventricular pacing improves cardiac resynchronization therapy in chronic asynchronous infarction and heart failure models.心内膜左心室起搏改善慢性非同步性梗塞和心力衰竭模型中的心脏再同步治疗。
Circ Arrhythm Electrophysiol. 2012 Feb;5(1):191-200. doi: 10.1161/CIRCEP.111.965814. Epub 2011 Nov 7.
5
Impact of mitral regurgitation on reverse remodeling and outcome in patients undergoing cardiac resynchronization therapy.二尖瓣反流对心脏再同步治疗患者逆重构和结局的影响。
Circ Cardiovasc Imaging. 2012 Jan;5(1):21-6. doi: 10.1161/CIRCIMAGING.111.966580. Epub 2011 Nov 2.
6
Device therapy in heart failure patients with chronic kidney disease.心力衰竭合并慢性肾脏病患者的器械治疗。
J Am Coll Cardiol. 2011 Aug 23;58(9):889-96. doi: 10.1016/j.jacc.2011.05.024.
7
The PR interval and cardiac resynchronization therapy outcomes: considering confounding, mediation, and effect modification.PR间期与心脏再同步治疗结果:考虑混杂因素、中介作用和效应修饰
Heart Rhythm. 2012 Jan;9(1):40-1. doi: 10.1016/j.hrthm.2011.08.010. Epub 2011 Aug 9.
8
Does cardiac resynchronization therapy provide unrecognized benefit in patients with prolonged PR intervals? The impact of restoring atrioventricular synchrony: an analysis from the COMPANION Trial.心脏再同步治疗是否为 PR 间期延长患者带来了未被认识到的益处?恢复房室同步的影响:来自 COMPANION 试验的分析。
Heart Rhythm. 2012 Jan;9(1):34-9. doi: 10.1016/j.hrthm.2011.07.038. Epub 2011 Aug 9.
9
Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.右心室导联位置并不影响心力衰竭伴心房颤动患者心脏再同步治疗的获益。
Europace. 2011 Dec;13(12):1747-52. doi: 10.1093/europace/eur193. Epub 2011 Jun 28.
10
Iron deficiency in community-dwelling US adults with self-reported heart failure in the National Health and Nutrition Examination Survey III: prevalence and associations with anemia and inflammation.美国社区居住的自我报告心力衰竭成年人中的缺铁情况:患病率及与贫血和炎症的关联。在全国健康和营养调查 III 中。
Circ Heart Fail. 2011 Sep;4(5):599-606. doi: 10.1161/CIRCHEARTFAILURE.111.960906. Epub 2011 Jun 24.